NAMS |
NewAmsterdam Pharma Co N.V. |
Jul 17, 2024 |
1 |
$0 |
4 |
Jul 19, 2024 |
Director |
NAMS |
NewAmsterdam Pharma Co N.V. |
Jul 16, 2024 |
0 |
$0 |
3 |
Jul 19, 2024 |
Director |
PCSC |
Perceptive Capital Solutions Corp |
Jun 11, 2024 |
0 |
$0 |
3 |
Jun 11, 2024 |
Director |
APGE |
Apogee Therapeutics, Inc. |
Jun 5, 2024 |
1 |
$0 |
4 |
Jun 7, 2024 |
Director |
HLXB |
Helix Acquisition Corp. II |
Feb 8, 2024 |
0 |
$0 |
3 |
Feb 8, 2024 |
Director |
SYRE |
Spyre Therapeutics, Inc. |
Feb 1, 2024 |
1 |
$0 |
4 |
Feb 5, 2024 |
Director |
SYRE |
Spyre Therapeutics, Inc. |
Feb 1, 2024 |
0 |
$0 |
3 |
Feb 5, 2024 |
Director |
APGE |
Apogee Therapeutics, Inc. |
Aug 17, 2023 |
2 |
$0 |
4 |
Aug 21, 2023 |
Director |
APGE |
Apogee Therapeutics, Inc. |
Aug 17, 2023 |
0 |
$0 |
3 |
Aug 21, 2023 |
Director |
RXDX |
Prometheus Biosciences, Inc. |
Jun 16, 2023 |
9 |
$0 |
4 |
Jun 16, 2023 |
Chairman, President and CEO, Director |
RXDX |
Prometheus Biosciences, Inc. |
Jun 2, 2023 |
4 |
$355K |
4 |
Jun 2, 2023 |
Chairman, President & CEO, Director |
RXDX |
Prometheus Biosciences, Inc. |
Mar 15, 2023 |
3 |
-$2.83M |
4 |
Mar 17, 2023 |
Chairman, President & CEO, Director |
RXDX |
Prometheus Biosciences, Inc. |
Mar 1, 2023 |
6 |
-$1.37M |
4 |
Mar 3, 2023 |
Chairman, President & CEO, Director |
RXDX |
Prometheus Biosciences, Inc. |
Feb 15, 2023 |
9 |
-$7.48M |
4 |
Feb 17, 2023 |
Chairman, President & CEO, Director |
RXDX |
Prometheus Biosciences, Inc. |
Jan 17, 2023 |
3 |
-$2.9M |
4 |
Jan 19, 2023 |
Chairman, President & CEO, Director |
RXDX |
Prometheus Biosciences, Inc. |
Dec 9, 2022 |
2 |
$0 |
4 |
Dec 13, 2022 |
Chairman, President & CEO, Director |
RXDX |
Prometheus Biosciences, Inc. |
May 20, 2022 |
1 |
$0 |
4 |
May 20, 2022 |
Chairman, President & CEO, Director |
RXDX |
Prometheus Biosciences, Inc. |
Dec 1, 2021 |
2 |
$44.7K |
4 |
Dec 3, 2021 |
Chairman, President & CEO, Director |
RXDX |
Prometheus Biosciences, Inc. |
Nov 14, 2021 |
1 |
$0 |
4 |
Nov 16, 2021 |
Chairman, President & CEO, Director |